Carly Kenselaar

Stock Analyst at Citigroup

(3.7)
# 135
Out of 5,270 analysts
6
Total ratings
100.00%
Success rate
86.21%
Average return
Main Sectors:
Top Industries:
2 Stocks
Name Action Price Target Current % Upside Ratings Updated
Travere Therapeutics
Maintains: Strong Buy
31 35
19.75 77.22% 5 Feb 24, 2025
Krystal Biotech
Initiates Coverage On: Buy
160
171.51 -6.71% 1 Oct 12, 2023